Abzena Enhances AbZelectPRO™ Cell Line Offering with New GS Knockout Platforms

SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its AbZelectPRO™ cell line development (CLD) platform with the launch of two next-generation Glutamine Synthetase ("GS") knockout...